We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+19.35%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$80.4B
AUM Growth
+$10.3B
(+15%)
Cap. Flow
-$1.63B
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
17.35%
Holding
1,869
New
81
Increased
811
Reduced
837
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$355M |
| 2 |
Yum China
YUMC
|
+$307M |
| 3 |
Elanco Animal Health
ELAN
|
+$298M |
| 4 |
Western Midstream Partners
WES
|
+$238M |
| 5 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$291M |
| 2 |
PepsiCo
PEP
|
+$260M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$258M |
| 4 |
Apple
AAPL
|
+$221M |
| 5 |
WES
Western Gas Partners Lp
WES
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.81% |
| 2 | Technology | 15.13% |
| 3 | Energy | 13.68% |
| 4 | Healthcare | 13.59% |
| 5 | Financials | 12.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TECD
676
DELISTED
Tech Data Corp
TECD
| $9.59M | 0.01% |
93,590
-11,620
| -11% | -$1.14M |
|
|
HMLP
677
DELISTED
HOEGH LNG PARTNERS LP
HMLP
| $9.46M | 0.01% |
484,142
-6,882
| -1% | -$123K |
|
678
Raymond James Financial
RJF
$31.9B
| $9.46M | 0.01% |
176,423
-231,843
| -57% | -$12.4M |
|
679
Outfront Media
OUT
$5.59B
| $9.37M | 0.01% |
406,726
+22,175
| +6% | +$465K |
|
680
Customers Bancorp
CUBI
$2.55B
| $9.26M | 0.01% |
505,897
+11,183
| +2% | +$223K |
|
681
Neurocrine Biosciences
NBIX
$17.4B
| $9.21M | 0.01% |
104,484
-494,699
| -83% | -$41.3M |
|
|
LM
682
DELISTED
Legg Mason, Inc.
LM
| $9.1M | 0.01% |
332,517
+304,156
| +1,072% | +$8.72M |
|
|
DESP
683
DELISTED
Despegar.com
DESP
| $9.01M | 0.01% |
604,880
+52,400
| +9% | +$829K |
|
|
CIT
684
DELISTED
CIT Group Inc.
CIT
| $8.98M | 0.01% |
187,253
-465,024
| -71% | -$21.9M |
|
|
FOLD
685
DELISTED
Amicus Therapeutics
FOLD
| $8.84M | 0.01% |
+650,240
| New | +$7.94M |
|
686
Amgen
AMGN
$198B
| $8.72M | 0.01% |
45,886
+33,365
| +266% | +$6.37M |
|
687
H&R Block
HRB
$4.99B
| $8.65M | 0.01% |
361,303
+39,819
| +12% | +$979K |
|
688
EQT Corp
EQT
$33.5B
| $8.61M | 0.01% |
414,881
+9,751
| +2% | +$191K |
|
689
Manitowoc
MTW
$509M
| $8.6M | 0.01% |
524,057
+11,769
| +2% | +$196K |
|
690
Steel Dynamics
STLD
$34.7B
| $8.54M | 0.01% |
242,134
-20,686
| -8% | -$735K |
|
|
CORE
691
DELISTED
Core Mark Holding Co., Inc.
CORE
| $8.51M | 0.01% |
229,301
-101,975
| -31% | -$3.21M |
|
|
DISH
692
DELISTED
DISH Network Corp.
DISH
| $8.42M | 0.01% |
265,791
-234,419
| -47% | -$7.18M |
|
|
ZEPP
693
Zepp Health
ZEPP
$74.4M
| $8.37M | 0.01% |
159,752
+74,113
| +87% | +$4M |
|
694
Alliance Resource Partners
ARLP
$3.19B
| $8.35M | 0.01% |
410,013
| – | – |
|
695
Madison Square Garden
MSGS
$9.49B
| $8.19M | 0.01% |
39,186
+1,678
| +4% | +$341K |
|
696
Acacia Research
ACTG
$444M
| $8.15M | 0.01% |
2,500,000
| – | – |
|
|
MDP
697
DELISTED
Meredith Corporation
MDP
| $8.15M | 0.01% |
147,452
+36,264
| +33% | +$2.01M |
|
|
JHG
698
DELISTED
Janus Henderson
JHG
| $8.08M | 0.01% |
323,450
+63,040
| +24% | +$1.46M |
|
|
ARRY
699
DELISTED
Array Biopharma Inc
ARRY
| $7.97M | 0.01% |
+327,010
| New | +$6.81M |
|
700
EOG Resources
EOG
$77.9B
| $7.95M | 0.01% |
83,543
-204,436
| -71% | -$19.5M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2019 Portfolio in Review
As of Q1 2019, OppenheimerFunds held 1,869 positions worth $80.4B, up 15% from $70.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
OppenheimerFunds's Q1 2019 filing shows 81 new, 811 increased, 837 reduced and 124 closed positions. Its largest new stake was Elanco Animal Health: 9,668,160 shares worth $310M. The largest sale was Pinduoduo, an estimated $291M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 15% a quarter earlier, followed by Technology and Energy.
- OppenheimerFunds's largest Q1 2019 buy was Elanco Animal Health: 9,668,160 shares worth $310M.
- OppenheimerFunds added most to Procter & Gamble in Q1 2019, an estimated $355M increase.
- OppenheimerFunds's biggest Q1 2019 reduction was Pinduoduo, cutting an estimated $291M.
- OppenheimerFunds fully exited Western Gas Partners Lp in Q1 2019, selling an estimated $215M.
- OppenheimerFunds's ten largest holdings make up 17% of its $80.4B portfolio in Q1 2019.
- OppenheimerFunds opened 81 new positions and closed 124 in Q1 2019.
- OppenheimerFunds's portfolio value rose 15% quarter-over-quarter to $80.4B.
Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.